Epigenome editing of aging: results of SynBioBeta 2026 https://ymaho.com/epigenome-editing-of-aging-results-of-synbiobeta-2026
At SynBioBeta 2026, cell stability engineering was presented: AI mapping of aging and proteostasis editing for treating age-related diseases. Learn the details of the breakthrough.
Reverse-age in Japan: how epigenetics reverses aging https://ymaho.com/reverse-age-in-japan-how-epigenetics-reverses-aging
The Japanese market is shifting from anti-age to reverse-age: epigenetics, exosomes, and senolytics. Find out who is winning the multi-billion dollar race for rejuvenation. Read the analysis.
Art Slows Aging: 4% Effect According to DunedinPACE https://ymaho.com/art-slows-aging-4-effect-according-to-dunedinpace
Epigenetic study by UCL proved: regular engagement with art slows biological aging by 4%, just like sports. Find out which practices work.
Nanotechnology against cancer chemoresistance: a review from EUR J CANCER https://ymaho.com/nanotechnology-against-cancer-chemoresistance-a-review-from-eur-j-cancer
Breakthrough in oncology: how nanoparticles and CRISPR epigenome editing reverse tumor resistance to chemotherapy. Learn about clinical successes in 2026.
Reverse Aging 2026: Japanese trend to turn back time https://ymaho.com/reverse-aging-2026-japanese-trend-to-turn-back-time
Japanese trend Reverse Aging 2026: epigenetics and senolytics reverse aging. Learn how reverse aging of the skin works without injections. Read.
Human Cell Rejuvenation Therapy Trials https://ymaho.com/human-cell-rejuvenation-therapy-trials
Learn about the first clinical trial of ER-100 cell rejuvenation therapy from Life Biosciences. How epigenetic reprogramming can reverse aging. Read details.
MitoQ: study of its effect on aging — a new standard? https://ymaho.com/mitoq-study-of-its-effect-on-aging-a-new-standard
Analysis of the clinical study of the antioxidant MitoQ and the epigenetic clock LinAge3: who benefits from the race for biological rejuvenation and what are the hidden risks. Learn the details.
SHARP Study: Personalized Therapy Against Aging https://ymaho.com/sharp-study-personalized-therapy-against-aging
How the SHARP clinical study with 1500 participants attempts to prove that biological aging can be slowed. Learn who will benefit from the validation of epigenetic clocks.
Senolytics and cell rejuvenation: Nature 2026 review https://ymaho.com/senolytics-and-cell-rejuvenation-nature-2026-review
Nature review of new life extension strategies: senolytics, senomorphics, and epigenetic rejuvenation. Key findings, timeline, and market winners. Read details.
Senolytic dasatinib+quercetin rejuvenated tissues by 2-3 years https://ymaho.com/senolytic-dasatinib-quercetin-rejuvenated-tissues-by-2-3-years
Senolytic drugs D+Q reduced biological age in humans for the first time. Learn how removing old cells rejuvenates the body. Read details of the breakthrough.